课题基金 / 基金详情

Macrophage migration inhibitory factor (MIF) as a Crucial Regulatory Cytokine and Therapeutic Target in Ankylosing Spondylitis

Macrophage migration inhibitory factor (MIF) as a Crucial Regulatory Cytokine and Therapeutic Target in Ankylosing Spondylitis
巨噬细胞迁移抑制因子（MIF）作为强直性脊柱炎的关键调节细胞因子和治疗靶点
批准号：
397552
负责人：
Nakamura Akihiro
金额：
$12.02万
依托单位：
University Health Network (Toronto)
依托单位国家：
加拿大
项目类别：
Fellowship Programs
财政年份：
2018
资助国家：
加拿大
项目状态：
已结题
起止时间：
2018-11-01 至 2021-11-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=397552&lang=en
关键词：
Ankylosing Spondylitis Inflammation Low Back Pain Macrophage Migration Inhibitory Factor New Bone Formation

项目摘要

项目成果

Nakamura Akihiro的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Ankylosing spondylitis (AS) is the most common form of spine arthritis which causes bones in the spine to fuse together, making the spine rigid and leading to severe low back pain (LBP). The main characteristics in AS are inflammation and abnormal new bon
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Intra-articular injection of miR-181a-5p inhibitor attenuates cartilage degeneration in both facet and knee osteoarthritis
海外基金